Our Terms of Service and Privacy Policy have changed.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
| 0.08 Delayed Data As of Sep 29 |  -0.004 / -4.76%Today’s Change | 0.06 Today|||52-Week Range 0.12 | -18.28% Year-to-Date |
| Previous close | 0.08 |
| Today’s open | 0.08 |
| Day’s range | 0.08 - 0.08 |
| Volume | 10,650 |
| Average volume (3 months) | 41,703 |
| Market cap | $33.8M |
| Dividend yield | -- |
| Earnings growth (last year) | -9.52% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -6.30% |
| P/E ratio | NM |
| Price/Sales | 5.52 |
| Price/Book | 9.61 |
| Today’s change | Today’s % change | |
|---|---|---|
| CGIXCancer Genetics Inc | 0.00 | 0.00% |
| GALTGalectin Therapeutic... | -0.18 | -12.86% |
| ERBERBA Diagnostics Inc | -0.05 | -9.58% |
| BMRABiomerica Inc | -0.11 | -3.94% |
| Last reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $7.1M |
| Annual profit (last year) | -$1.8M |
| Net profit margin | -25.75% |
Sector Health Technology |
Industry Medical Specialties |
President, Chief Executive Officer & Director Steve T. Laflin |
Chief Financial Officer & Secretary Laurie A. McKenzie-Carter |
Corporate headquarters Idaho Falls, Idaho |
